BLT1 and BLT2:: the leukotriene B4 receptors

被引:277
作者
Tager, AM
Luster, AD
机构
[1] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammat Dis, Charlestown, MA 02129 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Pulm & Crit Care Unit, Sch Med, Boston, MA 02114 USA
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2003年 / 69卷 / 2-3期
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0952-3278(03)00073-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two receptors for leukotriene B-4 (LTB4) have been molecularly identified: BLT1 and BLT2. Both receptors are G protein-coupled seven transmembrane domain receptors, whose genes are located in very close proximity to each other in the human and mouse genomes. The two receptors differ in their affinity and specificity for LTB4: BLT1 is a high-affinity receptor specific for LTB4, whereas BLT2 is a low-affinity receptor that also binds other eicosanoids. The two receptors also differ in their pattern of expression with BLT1 being expressed primarily in leukocytes, whereas BLT2 is expressed more ubiquitously. By mediating the activities of LTB4, these receptors participate both in host immune responses and in the pathogenesis of inflammatory diseases. Reduced disease severity in animal inflammatory models seen with LTB4 receptor antagonists and in mice with targeted deletion of BLT1 have revealed important roles for LTB4 and its receptors in regulating pathologic inflammation. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:123 / 134
页数:12
相关论文
共 95 条
[31]   Targeted disruption of the leukotriene B4 receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis [J].
Haribabu, B ;
Verghese, MW ;
Steeber, DA ;
Sellars, DD ;
Bock, CB ;
Snyderman, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) :433-438
[32]   N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes:: Molecular characterization of FPR2, a second mouse neutrophil FPR [J].
Hartt, JK ;
Barish, G ;
Murphy, PM ;
Gao, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (05) :741-747
[33]  
Hebert MJ, 1996, J IMMUNOL, V157, P3105
[34]   5-lipoxygenase and leukotriene B4 receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue [J].
Hennig, R ;
Ding, XZ ;
Tong, WG ;
Schneider, MB ;
Standop, J ;
Friess, H ;
Büchler, MW ;
Pour, PM ;
Adrian, TE .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (02) :421-428
[35]   LEUKOTRIENE-B4 RECEPTOR ANTAGONISTS - THE LY255283-SERIES OF HYDROXYACETOPHENONES [J].
HERRON, DK ;
GOODSON, T ;
BOLLINGER, NG ;
SWANSONBEAN, D ;
WRIGHT, IG ;
STATEN, GS ;
THOMPSON, AR ;
FROELICH, LL ;
JACKSON, WT .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (10) :1818-1828
[36]   LEUKOTRIENE-B4 ACTION ON ENDOTHELIUM MEDIATES AUGMENTED NEUTROPHIL ENDOTHELIAL ADHESION [J].
HOOVER, RL ;
KARNOVSKY, MJ ;
AUSTEN, KF ;
COREY, EJ ;
LEWIS, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (07) :2191-2193
[37]   NEUTROPHIL CHEMOTACTIC FACTORS IN BACTERIAL PNEUMONIA [J].
HOPKINS, H ;
STULL, T ;
VONESSEN, SG ;
ROBBINS, RA ;
RENNARD, SI .
CHEST, 1989, 95 (05) :1021-1027
[38]   Molecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophils [J].
Huang, WW ;
Garcia-Zepeda, EA ;
Sauty, A ;
Oettgen, HC ;
Rothenberg, ME ;
Luster, AD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (06) :1063-1074
[39]  
IYOBE T, 1996, SURG TODAY, V26, P419
[40]  
Kamohara M, 2000, J BIOL CHEM, V275, P27000